Blog Read the latest perspectives from our team of subject matter experts and others How H1 Integrates with Your CRM of ChoiceAt H1, we know that every life sciences organization has unique needs when it comes to customer relationship management (CRM). Some companies rely on long-established platforms, while others are adopting… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology CommercializationUnlocking Value-Based Care: How Pharma & MedTech Companies Can Thrive in a New Age of Private Payers and Population HealthAs the healthcare industry shifts to value-based care, private payers and population health are taking the lead in determining patient care. For pharma and med tech companies, this shift… Continue reading → Read the articleno CommercializationDrug DevelopmentKOL EngagementPatient RepresentationProvider DataH1 Honored with a Spot on Y Combinator’s 2023 Best Companies List and Slice of Healthcare’s Inaugural Digital Health Leaders ListH1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies… Continue reading → Read the articleno CommercializationKOL EngagementMedical Public Awareness Campaigns—Examples and EffectivenessMedical public awareness campaigns are designed to distribute important healthcare messages to large populations. With over seven billion people in the world, it is necessary to find ways to share… Continue reading → Read the article Drug DevelopmentPatient RepresentationBest-Fit Sites for Clinical TrialsWhen evaluating the feasibility of a clinical trial, it’s essential to consider what success means. This can mean defining criteria for your patient population, principal investigator (PI) qualifications, and… Continue reading → Read the articleno Patient RepresentationHow to Build a Scalable Patient Representation StrategyPut simply – in 2022, clinical trial diversity, equity and inclusion (DEI) was top of mind for the pharma and biotech industries, across all phases of drug and device… Continue reading → Read the articleno KOL EngagementTis the Season…for Conference PlanningAs we come out of the holidays , in the United States, some of the greatest minds in medicine and healthcare are gathered this week at the JP Morgan Healthcare… Continue reading → Read the articleno«‹567891011›»
